By Counterforce Health Team in Soliris (eculizumab) —

The Complete Guide to Getting Soliris (Eculizumab) Covered by Cigna in Texas: Forms, Appeals, and Success Strategies

Quick Answer: Getting Soliris (Eculizumab) Covered by Cigna in Texas

Cigna requires prior authorization for Soliris using their specific CCRD form with documented FDA-approved diagnosis (PNH, aHUS, gMG, or NMOSD), meningococcal vaccination proof, and REMS enrollment. If denied, Texas residents with fully-insured plans can appeal internally (180 days) and request Independent Review Organization (IRO) external review through the Texas Department of Insurance. First step today: verify your plan type on your ID card and gather diagnostic labs within 3 months.

Table of Contents

Who Should Use This Guide

This guide is for Texas patients and their healthcare providers seeking Cigna coverage for Soliris (eculizumab) for FDA-approved conditions: paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), or neuromyelitis optica spectrum disorder (NMOSD).

Expected outcome: With proper documentation and submission, initial approvals often succeed within 72 hours. If denied, Texas's robust appeal process—including independent external review—provides additional pathways, with specialty drug appeals frequently overturned when clinical evidence is comprehensive.

Member & Plan Basics

Verify Your Coverage Type

Check your Cigna ID card for plan details:

  • Fully-insured plans (TDI regulated): Follow Texas-specific appeal rights
  • Self-funded ERISA plans: Federal appeal process applies
  • Medicare Advantage: CMS appeal pathway
Note: Call the customer service number on your ID card to confirm your specific plan type and formulary status.

Coverage Requirements at a Glance

Requirement Details Source
Prior Authorization Required for all indications Cigna Policy
Formulary Status Covered with restrictions Cigna Formulary
Step Therapy Documentation of prior therapies required Cigna Policy
Specialist Required Hematologist (PNH/aHUS) or neurologist (gMG/NMOSD) Cigna Policy
REMS Compliance Mandatory vaccination and enrollment FDA REMS

Clinical Criteria for Approval

Cigna approves Soliris for patients ≥18 years with documented FDA-approved diagnoses and specific clinical criteria:

Diagnosis-Specific Requirements

Paroxysmal Nocturnal Hemoglobinuria (PNH):

  • Flow cytometry showing GPI-anchored protein deficiency on ≥2 cell lineages
  • Elevated LDH levels
  • Transfusion history documentation
  • Prescribed by hematologist

Atypical Hemolytic Uremic Syndrome (aHUS):

  • Confirmed not Shiga toxin E. coli-related HUS
  • Evidence of thrombocytopenia and hemolytic anemia
  • Complement studies ruling out STEC
  • Prescribed by hematologist

Generalized Myasthenia Gravis (gMG):

  • Anti-AChR antibody positive
  • MG-ADL score ≥6 (if ≥18 years)
  • Symptoms affecting daily function
  • Prescribed by neurologist

Neuromyelitis Optica Spectrum Disorder (NMOSD):

  • Positive anti-aquaporin-4 (AQP4) antibody
  • Documented relapsing episodes
  • Prescribed by neurologist

Universal Safety Requirements

All patients must have:

  • Meningococcal vaccinations (MenACWY and MenB) ≥2 weeks before first dose
  • Prescriber enrolled in Soliris REMS program
  • Patient Safety Card issued

Required Documentation Package

Core Documents Needed

  1. Completed Prior Authorization Form
    • Use Cigna's Soliris CCRD form (v081525)
    • Include prescriber DEA/NPI/TIN
    • Patient Cigna ID and demographics
    • Administration site details
  2. Letter of Medical Necessity
    • Diagnosis with date
    • Clinical symptoms and severity
    • Laboratory results (≤3 months old)
    • Prior therapy history and outcomes
    • Rationale for Soliris over alternatives
  3. Supporting Clinical Documentation
    • Specialist evaluation (≤30 days)
    • Relevant lab results
    • Vaccination records
    • REMS enrollment confirmation

Clinician Corner: Medical Necessity Letter Essentials

Your letter should address these key elements:

  • Patient identification: Full demographics and insurance details
  • Diagnosis confirmation: Specific tests and results supporting FDA indication
  • Disease severity: Quantifiable measures (transfusion frequency, MG-ADL scores)
  • Treatment history: Prior medications, doses, duration, and reasons for discontinuation
  • Clinical rationale: Why Soliris is medically necessary and appropriate
  • Monitoring plan: How you'll assess response and safety
Tip: Reference specific sections of Cigna's coverage policy to demonstrate you're meeting their exact criteria.

Submission Process

Step-by-Step Submission

  1. Gather All Documentation (Patient/Clinic)
    • Complete forms and supporting documents
    • Verify all signatures and dates
    • Expected time: 1-2 business days
  2. Submit Via Preferred Method
    • Online: CoverMyMeds portal (fastest)
    • Fax: 855-840-1678 (Soliris-specific) or 866-873-8279 (general)
    • Phone: 800-882-4462 (urgent cases)
  3. Request Expedited Review if Appropriate
    • Check "urgent" box on form
    • Attest to serious jeopardy to health
    • Expected response: 24 hours vs. 72 hours standard
  4. Obtain Confirmation
    • Record submission confirmation number
    • Note expected response date
    • Save all submitted documents

Specialty Pharmacy Routing

Soliris is typically dispensed through Cigna's specialty pharmacy network, primarily Accredo:

Transfer Process

  1. Prescription Routing: Provider sends prescription to Accredo
  2. Benefits Verification: Accredo confirms coverage and copay
  3. Shipment Coordination: Temperature-controlled delivery arranged
  4. Administration Setup: Coordinate with infusion center or home health
Note: Soliris bills under medical benefit, not pharmacy benefit, requiring proper HCPCS coding (J1299 for dates after April 1, 2025).

After Submission: Tracking Your Request

Timeline Expectations

  • Standard review: 72 hours (3 business days)
  • Expedited review: 24 hours
  • Additional information requests: May extend timeline

Status Monitoring

  • Check Cigna provider portal for updates
  • Call customer service with confirmation number
  • Document all communications with dates and representatives

Counterforce Health helps patients and providers navigate complex prior authorization processes by analyzing denial letters and creating targeted, evidence-based appeals. Their platform can identify specific denial reasons and draft point-by-point rebuttals aligned with payer policies, potentially improving approval success rates.

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documents
Insufficient diagnostic documentation Submit complete lab results and specialist evaluation Flow cytometry (PNH), antibody tests, imaging
Missing vaccination records Provide vaccination dates ≥2 weeks before treatment CDC vaccination record, pharmacy documentation
REMS enrollment incomplete Complete prescriber and patient enrollment REMS confirmation certificates
Prior therapy not documented Detail previous treatments and outcomes Pharmacy records, physician notes
Medical necessity unclear Strengthen clinical rationale with guidelines Peer-reviewed studies, society recommendations

Texas Appeals Process

Internal Appeal Process

Timeline: Must file within 180 days of denial notice

Level 1 Appeal:

  1. Submit appeal form via Cigna portal, fax, or mail
  2. Include original denial notice and all supporting documentation
  3. Response time: 30 days for pre-service, 60 days for post-service
  4. Fax: 866-567-2474 (medical appeals)

Level 2 Appeal (if Level 1 denied):

  1. File within 60 days of Level 1 denial
  2. Independent clinical reviewer evaluates case
  3. Response time: up to 75 business days

External Review (Texas IRO Process)

For fully-insured plans regulated by Texas Department of Insurance:

Eligibility: Medical necessity or experimental/investigational denials Timeline: Request within 4 months of final internal denial Process:

  1. Complete IRO request form provided with denial letter
  2. Submit to Texas Department of Insurance
  3. Independent medical experts review case
  4. Decision rendered within 20 days (5 days for urgent)
  5. Binding decision: If overturned, Cigna must comply

Texas Resources:

Quick Reference Checklist

Before Submitting

  • Confirm FDA-approved diagnosis with supporting labs
  • Obtain specialist evaluation (hematologist or neurologist)
  • Complete meningococcal vaccinations ≥2 weeks prior
  • Enroll prescriber in REMS program
  • Document prior therapy history
  • Complete Cigna Soliris CCRD form
  • Draft comprehensive medical necessity letter

Submission Day

  • Submit via CoverMyMeds or fax to 855-840-1678
  • Request expedited review if clinically urgent
  • Obtain and record confirmation number
  • Note expected response date
  • Save copies of all submitted documents

If Denied

  • Review denial letter for specific reasons
  • Gather additional supporting documentation
  • File Level 1 appeal within 180 days
  • Consider peer-to-peer review request
  • Prepare for potential IRO external review

FAQ

How long does Cigna prior authorization take for Soliris in Texas? Standard review is 72 hours; expedited review is 24 hours for urgent cases where delay could jeopardize health.

What if Soliris is non-formulary on my Cigna plan? You can request a formulary exception with clinical justification. The same documentation requirements apply, but emphasize why formulary alternatives are inappropriate.

Can I request an expedited appeal in Texas? Yes, both internal appeals and IRO external reviews can be expedited if delay would seriously jeopardize your health, life, or ability to regain maximum function.

Does step therapy apply if I failed treatments outside Texas? Yes, document all prior therapies regardless of where they were tried. Cigna accepts treatment history from any licensed provider.

What's the success rate for Soliris appeals in Texas? While specific data isn't available, specialty drug appeals often succeed when comprehensive clinical evidence is provided, particularly through the IRO external review process.

Who pays for the Independent Review Organization process? Cigna pays all costs for the IRO review. There's no charge to patients or providers for this external appeal process.

Can my doctor request a peer-to-peer review? Yes, physicians can request to speak directly with Cigna's medical director to discuss the case, which often resolves denials without formal appeals.

What if I have both Cigna and Medicare? Coordination of benefits rules apply. The primary insurer processes first, and different appeal procedures may apply depending on which plan is primary.

From our advocates: We've seen cases where initial Soliris denials were overturned simply by providing more detailed vaccination documentation and clarifying the administration site. Sometimes it's not about the clinical necessity but ensuring all procedural requirements are crystal clear in the submission.

For complex cases or if you need assistance navigating the prior authorization process, Counterforce Health specializes in turning insurance denials into successful appeals by analyzing payer-specific requirements and crafting evidence-based responses.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual circumstances and plan terms. Always consult with your healthcare provider and insurance company for personalized guidance. For assistance with Texas insurance disputes, contact the Texas Department of Insurance at 1-800-252-3439.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.